Inozyme Pharma has a total of 128 patents globally, out of which 17 have been granted. Of these 128 patents, more than 76% patents are active. Japan is where Inozyme Pharma has filed the maximum number of patents, followed by Canada and Hong Kong. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Inozyme Pharma.
Inozyme Pharma founded in 2015, Inozyme Pharma is a clinical-stage biopharmaceutical company developing novel therapies for rare diseases affecting bone health and blood vessel function. The company focuses on treating genetic disorders caused by ENPP1 and ABCC6 deficiencies. Its lead candidate, INZ-701, is a genetically engineered fusion protein designed to address defects in these disease pathways.
Do read about some of the most popular patents of Inozyme Pharma which have been covered by us in this article and also you can find Inozyme Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Inozyme Pharma patent portfolio.
How many patents does Inozyme Pharma have?
Inozyme Pharma has a total of 128 patents globally. These patents belong to 15 unique patent families. Out of 128 patents, 99 patents are active.
How Many Patents did Inozyme Pharma File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Inozyme Pharma Applications Filed | Inozyme Pharma Patents Granted |
| 2026 | – | 1 |
| 2025 | 4 | 3 |
| 2024 | 6 | 7 |
| 2023 | 19 | 1 |
| 2022 | 17 | 1 |
| 2021 | 54 | 2 |
| 2020 | 10 | – |
| 2018 | 4 | 1 |
| 2017 | 2 | 1 |
| 2015 | 9 | – |
How many Inozyme Pharma patents are Alive/Dead?
Worldwide Patents

How Many Patents did Inozyme Pharma File in Different Countries?

Countries in which Inozyme Pharma Filed Patents
| Country | Patents |
| Japan | 13 |
| Canada | 12 |
| Hong Kong (S.A.R.) | 12 |
| Europe (EPO) | 10 |
| Korea (South) | 9 |
| Taiwan | 8 |
| Israel | 7 |
| Brazil | 7 |
| Mexico | 7 |
| Colombia | 6 |
| India | 6 |
| Italy | 4 |
| Australia | 4 |
| China | 4 |
| Russia | 3 |
| Argentina | 2 |
| Poland | 1 |
| Turkey | 1 |
| Norway | 1 |
Where are Research Centres of Inozyme Pharma Patents Located?

10 Best Inozyme Pharma Patents
WO2020150716A1 is the most popular patent in the Inozyme Pharma portfolio. It has received 8 citations.
What are Inozyme Pharma key innovation segments?
What Technologies are Covered by Inozyme Pharma?

The chart below distributes patents filed by Inozyme Pharma